3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Anxiety Disorders
2
Testicular Germ Cell Tumor
1
Sarcoma
1
Ovarian Neoplasms
1
Leukemia, Myeloid, Acute
1
Depression
1
Breast Neoplasms
1
Interventions
anlotinib
3
Injections
3
Doxorubicin
3
toripalimab
1
spartalizumab
1
penpulimab
1
pemigatinib
1
pazopanib
1
montelukast
1
liposomal doxorubicin
1
eribulin
1
chlorhexidine gluconate
1
camrelizumab
1
bexmarilimab
1
apatinib
1
X-Rays
1
Trabectedin
1
Temozolomide
1
Tablets
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Radiotherapy
1
Proton Therapy
1
Positron Emission Tomography Computed Tomography
1
Nivolumab
1
Neoadjuvant Therapy
1
Negative-Pressure Wound Therapy
1
KP 1339
1
Ipilimumab
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Sarcoma
×
Hypnosis
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled